Come up with a name for your new list and we'll add to it:
Molecular Templates raised a round of funding on October 08, 2013. Investors include
Cancer Prevention and Research Institute of Texas.
Molecular Templates is a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics with advantages over existing Antibody Drug Conjugates (ADC…